Azoospermia – success rate of stem cells treatment is up to 76%!!!

Azoospermia is a condition in which there are no live or mature sperm in a man’s ejaculate. Ejaculate may contain sperm with other cells, so the presence of liquid ejaculate does not imply the presence of sperm. OBSERVE : New Protocol of Azoospermia Treatment

Azoospermia can be divided into two main categories:

Obstructive Azoospermia: When obstruction is present, sperm cannot be released into the ejaculate, even if active sperm production is occurring. Obstructive azoospermia can be caused by a number of reasons.

Today, the main cause of obstructive azoospermia is vasectomy, which the patient should be aware of. However, there are other problems that can block sperm from reaching the ejaculate. These problems include: Problems with the duct system through which sperm must travel to reach the urethra.

Once the sperm leaves the testes (which are the site of production), it passes through several other structures. These structures are the epididymis, the vas deferens (sometimes called the vas deferens), the ejaculatory duct, and the urethra. Any problem related to the transport of sperm from one structure to another or even within these structures can block the sperm’s exit path.
Ejaculation problems, in which the emission process may be disrupted. Sperm usually settle in the urethra before ejaculation. This is known as emission. It may not work properly due to neurological damage or, in some cases, uncontrolled diabetes, chronic inflammation.
In cases of obstructive azoospermia, the use of stem therapy can improve the quality and quantity of live sperm, which often helps to obtain an acceptable number of sperm for use during an IVF cycle.

Stem cell therapy for non-obstructive azoospermia: how does it work?
Stem cell therapy for azoospermia can be carried out in two ways. One of these methods is the systemic administration of stem cells through intravenous infusion, and the other is the injection of stem cells directly into the testicular cavernous bodies. The combined injection method provides more favorable results in practice.
In our clinic we use several types of stem cells: mesenchymal stem cells + exosomes + progenitor cells. The combination cocktail is then injected into specific areas of both testicles to restart spermatogenesis.
Stem cell therapy can recreate a new, healthy network of blood vessels in the prostate gland, increasing the production and transport of sperm from the testicles. This allows you to completely restore the function of the receptors located in the vascular walls and ducts of the prostate, and thereby stop the stagnation of tissue in the prostate gland, improve spermatogenesis, and reduce atrophy. Azoospermia Treatment with Stem Cells: Patient Case Study

Umbilical Cord Mesenchymal Cells – Source of Healing

To treat this disease, we recommend using umbilical cord MSC cells as the main cell feed, since they are the most effective, capable of differentiating into any cells and have strong cellular regeneration abilities.

Expected results after treatment:

– Elimination of hypogonadism caused by hormonal disorders

– Elimination of infectious and inflammatory processes in the genitourinary system

– Improvement of spermatogenesis, sperm quality

– Elimination of cicatricial and adhesive changes in tissues – improving the patency of the vas deferens

– Restoration of testicular function

What are exosomes, why are they added to injections?
Exosomes are tiny nanovesicles found in the interstitial space as well as in body fluids. Thanks to advances in the medical field, it is now known that exosomes are part of an elaborate intracellular communication system.
Exosomes are known to participate in all types of cellular communication.

They provide local autocrine signals between similar cell types, local paracrine signals between different cell types, as well as distant endocrine signals. Participation in such extensive cellular signaling gives them the name “signalosomes.” When exosomes are introduced into the body, they improve communication across all channels, which improves overall cellular health and function.
Compared to adult stem cells, exosomes contain 300% more growth factors, which are essential for cellular growth, development and regeneration. Exosomes can be administered intravenously or targeted to a specific site by direct injection.

Why are progenitor cells introduced?
The expanded vascular branch provides good blood flow, which provides excellent tissue nutrition and, as a result, restoration of lost functions. That is why we add progenitor cells to the overall composition, which can improve tissue traffic and fill the genital system with health.
We also use new biotechnologies in therapy, biohormonal granules, which eliminate the problem of hypogonadism, improve the entire hormonal balance, which stimulates sperm production and its quality.

What tests are needed before stem cell therapy?
Before stem cell therapy, several tests must be performed, or the patient’s existing studies must be provided.
The first step is to obtain all relevant test results, which include:
1) Sperm analysis and biopsy results
2) Blood tests including alpha fetoprotein (AFP) and beta human chorionic gonadotropin (b-hCG).
3) General biochemical blood tests
4) Hormonal and endocrine tests
5) Ultrasound of the pelvic organs

OUR APPROACH IN TREATMENT AZOOSPERMIA READ ON THIS PAGE:

Stem Cell Treatment of Azoospermia: Advanced Regenerative Therapy for Male Infertility

Success rate of stem cell therapy for male infertility:
In the short period of time since introducing this treatment, we have achieved success in a large number of patients who previously had zero sperm count in their ejaculate and who had unsuccessfully undergone sperm retrieval surgery. Although the number of patients treated, the time elapsed after treatment, and how long spermatogenesis can be maintained after stem cell therapy are all important factors in assessing how successful the treatment is, results so far show about 64-76% success in producing new sperm in patients with non-obstructive azoospermia.
The success of any type of fertility treatment will depend on several conditions, and general success rates may not always apply equally to everyone.
For an individual assessment, please contact our specialists, request additional information by phone: +380972524876 or info@bioage.com.ua